Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-24 @ 11:53 PM
NCT ID:
NCT00064051
Brief Title:
3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
Official Title:
A Phase II Study of Triapine in Combination With Gemcitabine in Patients With Pancreatic Cancer
Study:
NCT00064051
Protocol Section:
NCT00064051